Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma
Background: Immunogenic cell death (ICD) is related to cancer prognosis, which has a synergic effect in combination with chemotherapy or immunotherapy. Yet, the relationship between ICD and osteosarcoma remained unclear. Materials and methods: Three osteosarcoma datasets including therapeutically ap...
Main Authors: | Shuai Han, Qinghe Wang, Mingquan Shen, Xingpeng Zhang, Jian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024036612 |
Similar Items
-
Identification of immunogenic cell death gene-related subtypes and risk model predicts prognosis and response to immunotherapy in ovarian cancer
by: Wenjing Pan, et al.
Published: (2024-12-01) -
Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer
by: Xuejun Gan, et al.
Published: (2023-03-01) -
Pan‐cancer analyses of immunogenic cell death‐derived gene signatures: Potential biomarkers for prognosis and immunotherapy
by: Xiaodan Han, et al.
Published: (2024-04-01) -
Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma
by: Weidong Chen, et al.
Published: (2024-01-01) -
Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
by: Yingshu Cui, et al.
Published: (2023-08-01)